BACKGROUND: Severe infections play an important role in the emergency department (ED) and early risk stratification is essential. We compared the prognostic value of APACHE II, SOFA, and MEDS scores, and the biomarkers C-reactive protein (CRP), procalcitonin (PCT), and interleukin 6 (IL-6). METHODS: We performed a prospective observational study. Patients aged 18 years or older with a severe infection, from whom blood cultures were taken, were included. RESULTS: Two hundred and eleven patients were included. The 30-day mortality rate was 8.5%. All scores and biomarkers showed significant area under the curve (AUC) values of receiver operating characteristic curve analysis for death within 30 days: 0.801 for APACHE II, 0.785 for MEDS, 0.708 for SOFA, 0.693 for CRP, 0.651 for PCT, and 0.716 for IL-6. For treatment in an ICU and need for mechanical ventilation, these parameters had significant AUC values, too. For renal replacement therapy, only APACHE II, SOFA, and PCT showed significant AUC values. According to the trend observed, the AUC values were highest for the APACHE II score. CONCLUSIONS: All investigated parameters have a predictive value in patients with an infection in the ED. According to the trend observed, the APACHE II score seems to have the best discriminative power. Use of the APACHE II score already at the time of admission to the ED may be useful for stratifying patients at risk for ICU treatment, thereby using the same score in the ED and the ICU.
BACKGROUND: Severe infections play an important role in the emergency department (ED) and early risk stratification is essential. We compared the prognostic value of APACHE II, SOFA, and MEDS scores, and the biomarkers C-reactive protein (CRP), procalcitonin (PCT), and interleukin 6 (IL-6). METHODS: We performed a prospective observational study. Patients aged 18 years or older with a severe infection, from whom blood cultures were taken, were included. RESULTS: Two hundred and eleven patients were included. The 30-day mortality rate was 8.5%. All scores and biomarkers showed significant area under the curve (AUC) values of receiver operating characteristic curve analysis for death within 30 days: 0.801 for APACHE II, 0.785 for MEDS, 0.708 for SOFA, 0.693 for CRP, 0.651 for PCT, and 0.716 for IL-6. For treatment in an ICU and need for mechanical ventilation, these parameters had significant AUC values, too. For renal replacement therapy, only APACHE II, SOFA, and PCT showed significant AUC values. According to the trend observed, the AUC values were highest for the APACHE II score. CONCLUSIONS: All investigated parameters have a predictive value in patients with an infection in the ED. According to the trend observed, the APACHE II score seems to have the best discriminative power. Use of the APACHE II score already at the time of admission to the ED may be useful for stratifying patients at risk for ICU treatment, thereby using the same score in the ED and the ICU.
Authors: Michael D Howell; Michael W Donnino; Daniel Talmor; Peter Clardy; Long Ngo; Nathan I Shapiro Journal: Acad Emerg Med Date: 2007-06-18 Impact factor: 3.451
Authors: Mitchell M Levy; R Phillip Dellinger; Sean R Townsend; Walter T Linde-Zwirble; John C Marshall; Julian Bion; Christa Schorr; Antonio Artigas; Graham Ramsay; Richard Beale; Margaret M Parker; Herwig Gerlach; Konrad Reinhart; Eliezer Silva; Maurene Harvey; Susan Regan; Derek C Angus Journal: Crit Care Med Date: 2010-02 Impact factor: 7.598
Authors: Matthew C Strehlow; Stephen D Emond; Nathan I Shapiro; Andrea J Pelletier; Carlos A Camargo Journal: Ann Emerg Med Date: 2006-06-22 Impact factor: 5.721
Authors: Nathan I Shapiro; Richard E Wolfe; Richard B Moore; Eric Smith; Elizabeth Burdick; David W Bates Journal: Crit Care Med Date: 2003-03 Impact factor: 7.598
Authors: Martijn D de Kruif; Maarten Limper; Herman Gerritsen; C Arnold Spek; Dees P M Brandjes; Hugo ten Cate; Patrick M Bossuyt; Pieter H Reitsma; Eric C M van Gorp Journal: Crit Care Med Date: 2010-02 Impact factor: 7.598
Authors: Karl Werdan; Günter Pilz; Ursula Müller-Werdan; Monika Maas Enriquez; Dierk V Schmitt; Friedrich-Wilhelm Mohr; Gertraud Neeser; Friedrich Schöndube; Hans-Joachim Schäfers; Axel Haverich; Peter Fraunberger; Jan Andersson; Eckart Kreuzer; Lambert G Thijs Journal: Crit Care Med Date: 2008-03 Impact factor: 7.598
Authors: H Bryant Nguyen; Jim E Banta; Thomas W Cho; Chad Van Ginkel; Kristy Burroughs; William A Wittlake; Stephen W Corbett Journal: Shock Date: 2008-07 Impact factor: 3.454
Authors: S A Kaulen; C Hübner; J Mieth; K Spindler; R Schwab; R Wimmer; J Wilhelm; M Amoury; M Girndt; K Werdan; H Ebelt Journal: Med Klin Intensivmed Notfmed Date: 2014-09-03 Impact factor: 0.840
Authors: Michael W Donnino; Justin D Salciccioli; Andre Dejam; Tyler Giberson; Brandon Giberson; Cristal Cristia; Shiva Gautam; Michael N Cocchi Journal: Resuscitation Date: 2012-11-20 Impact factor: 5.262
Authors: Min Ho Seo; Minhong Choa; Je Sung You; Hye Sun Lee; Jung Hwa Hong; Yoo Seok Park; Sung Phil Chung; Incheol Park Journal: Yonsei Med J Date: 2016-11 Impact factor: 2.759
Authors: Noortje Zelis; Robin Hundscheid; Jacqueline Buijs; Peter W De Leeuw; Maarten Tm Raijmakers; Sander Mj van Kuijk; Patricia M Stassen Journal: BMJ Open Date: 2021-01-31 Impact factor: 2.692